Iron in parkinsonian and control substantia nigra—A mössbauer spectroscopy study

We used Mössbauer spectroscopy to study the iron content, the redox state, and the binding site of iron in substantia nigra (SN) from parkinsonian (PD) and control brains. Measurements performed on fresh‐frozen, formalin‐fixed, and lyophilized samples demonstrated the presence of ferric (Fe3+) iron only, both in PD and control SN. Ferrous iron, if present at all, may represent at most 5% of the total iron. We found no difference in the total amount of iron in SN between PD and control brains. The Mössbauer spectra observed at 4.1 K in fresh (frozen or lyophilized) samples were different from those obtained in formalin‐fixed (frozen or lyophilized) samples. In the fresh samples, only ferritin‐like iron was observed, whereas in the samples frozen or lyophilized from formalin, non‐ferritin iron was detected.

[1]  K. Jellinger,et al.  Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.

[2]  E. Bauminger,et al.  Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Lees,et al.  What features improve the accuracy of clinical diagnosis in Parkinson's disease , 1992, Neurology.

[4]  C D Marsden,et al.  Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.

[5]  P D Griffiths,et al.  Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. , 1993, Dementia.

[6]  Y. Agid,et al.  Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis , 1991, Journal of neurochemistry.

[7]  R. Uitti,et al.  Regional Metal Concentrations in Parkinson's Disease, Other Chronic Neurological Diseases, and Control Brains , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[8]  H. M. Swartz,et al.  Total and paramagnetic metals in human substantia nigra and its neuromelanin , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[9]  P. Harrison,et al.  Mössbauer spectroscopic study of the initial stages of iron-core formation in horse spleen apoferritin: evidence for both isolated Fe(III) atoms and oxo-bridged Fe(III) dimers as early intermediates. , 1989, Biochemistry.

[10]  M. Barcikowska,et al.  Does iron play a role in Parkinson's disease? , 1994 .

[11]  C. Marsden,et al.  Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.

[12]  P. Riederer,et al.  Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? , 1994, Journal of neurochemistry.

[13]  W. Koller.  How accurately can Parkinson's disease be diagnosed? , 1992, Neurology.

[14]  B. Halliwell.  Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? , 1989, Acta neurologica Scandinavica. Supplementum.

[15]  S. Fahn,et al.  Study of movement disorders and brain iron by MR. , 1987, AJR. American journal of roentgenology.

[16]  P. Riederer,et al.  Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? , 1989, Acta neurologica Scandinavica. Supplementum.

[17]  K. Jellinger,et al.  Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[18]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[19]  C. Marsden,et al.  Complex I, Iron, and ferritin in Parkinson's disease substantia nigra , 1994, Annals of neurology.

[20]  P. Harrison,et al.  Mössbauer spectroscopic investigation of structure-function relations in ferritins. , 1991, Biochimica et biophysica acta.

[21]  A Jacobs,et al.  Low molecular weight intracellular iron transport compounds. , 1977, Blood.

[22]  R. Cohen.  Improvements on Electromagnetic Velocity Drive for Mössbauer Experiments , 1966 .

[23]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[24]  B. Djahanguiri,et al.  The prevention of acute gastric ulcer in the rat by alpha-methyldopa. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.

[25]  P. Riederer,et al.  The possible role of iron in the etiopathology of parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[26]  P. Boesiger,et al.  T2 relaxation time in patients with Parkinson's disease , 1993, Neurology.

[27]  M. Blume,et al.  Mössbauer Spectra in a Fluctuating Environment , 1968 .

[28]  L. H. Bowen,et al.  Mössbauer spectroscopy. , 1988, Analytical chemistry.

[29]  Peter Riederer,et al.  Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.

[30]  B. Halliwell,et al.  Iron and free radical reactions: two aspects of antioxidant protection , 1986 .

[31]  S. Fahn,et al.  The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.

[32]  M. G. Bridelli,et al.  Comparative Mössbauer and infrared analysis of iron-containing melanins , 1982 .

[33]  K. Earle.  Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. , 1968, Journal of neuropathology and experimental neurology.

[34]  N. N. Greenwood,et al.  High-spin Iron Complexes , 1971 .

[35]  R. Frankel,et al.  Reduction of mammalian ferritin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Weir,et al.  Mössbauer spectroscopic studies of human haemosiderin and ferritin. , 1984, Biochimica et biophysica acta.

[37]  D. Calne.  The free radical hypothesis in idiopathic parkinsonism: Evidence against it , 1992, Annals of neurology.

[38]  C. W. Olanow,et al.  Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.

[39]  R. Hollatz,et al.  A fingerprint technique using Mössbauer spectroscopy for the determination of individual chemical iron species in young sediments , 1990 .